Vanguard Group’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $3.87K | Hold |
|
|||||
2024
Q1 | $23.1K | Hold |
|
|||||
2023
Q4 | $84.4K | Buy |
|
|||||
2023
Q3 | $43.2K | Buy |
|
|||||
2023
Q2 | $37.2K | Sell |
|
|||||
2023
Q1 | $114K | Hold |
|
|||||
2022
Q4 | $203K | Buy |
|
|||||
2022
Q3 | $305K | Sell |
|
|||||
2022
Q2 | $273K | Sell |
|
|||||
2022
Q1 | $471K | Sell |
|
|||||
2021
Q4 | $1.18M | Hold |
|
|||||
2021
Q3 | $2.96M | Hold |
|
|||||
2021
Q2 | $3.73M | Buy |
|
|||||
2021
Q1 | $4.11M | Buy |
|
|||||
2020
Q4 | $73K | Hold |
|
|||||
2020
Q3 | $72K | Hold |
|
|||||
2020
Q2 | $94K | Hold |
|
|||||
2020
Q1 | $71K | Hold |
|
|||||
2019
Q4 | $164K | Sell |
|
|||||
2019
Q3 | $137K | Sell |
|
|||||
2019
Q2 | $359K | Sell |
|
|||||
2019
Q1 | $379K | Buy |
|
|||||
2018
Q4 | $319K | Buy |
|